Sana Biotechnology, Inc. (SANA)
2.33
-0.04
(-1.69%)
USD |
NASDAQ |
Oct 23, 16:00
2.32
-0.01
(-0.43%)
After-Hours: 20:00
Sana Biotechnology Price : 2.33 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.35 | 2.38 | 2.245 | 2.33 | 1.708M |
| Oct 22, 2026 | 2.325 | 2.44 | 2.28 | 2.37 | 2.429M |
| Oct 21, 2026 | 2.38 | 2.39 | 2.315 | 2.35 | 2.402M |
| Oct 20, 2026 | 2.27 | 2.42 | 2.25 | 2.36 | 3.526M |
| Oct 19, 2026 | 2.32 | 2.359 | 2.22 | 2.30 | 2.629M |
| Oct 16, 2026 | 2.46 | 2.51 | 2.25 | 2.27 | 3.089M |
| Oct 15, 2026 | 2.36 | 2.51 | 2.35 | 2.475 | 2.916M |
| Oct 14, 2026 | 2.37 | 2.430 | 2.32 | 2.33 | 2.767M |
| Oct 13, 2026 | 2.60 | 2.635 | 2.37 | 2.41 | 4.911M |
| Oct 12, 2026 | 2.77 | 2.77 | 2.59 | 2.62 | 2.674M |
| Oct 09, 2026 | 2.79 | 2.87 | 2.770 | 2.79 | 2.918M |
| Oct 08, 2026 | 2.72 | 2.81 | 2.66 | 2.79 | 4.515M |
| Oct 07, 2026 | 2.71 | 2.845 | 2.70 | 2.72 | 4.315M |
| Oct 06, 2026 | 2.94 | 2.975 | 2.74 | 2.75 | 3.759M |
| Oct 05, 2026 | 2.90 | 2.93 | 2.82 | 2.88 | 5.394M |
| Oct 02, 2026 | 2.95 | 3.00 | 2.855 | 2.89 | 3.498M |
| Oct 01, 2026 | 2.89 | 3.05 | 2.85 | 2.89 | 3.771M |
| Sep 30, 2026 | 2.97 | 3.045 | 2.855 | 2.915 | 3.246M |
| Sep 29, 2026 | 2.945 | 3.055 | 2.89 | 2.91 | 3.048M |
| Sep 28, 2026 | 2.92 | 2.98 | 2.86 | 2.93 | 2.266M |
| Sep 25, 2026 | 2.96 | 3.00 | 2.90 | 2.945 | 2.880M |
| Sep 24, 2026 | 3.04 | 3.047 | 2.88 | 2.96 | 3.509M |
| Sep 23, 2026 | 3.33 | 3.33 | 3.014 | 3.08 | 3.840M |
| Sep 22, 2026 | 3.15 | 3.360 | 3.10 | 3.33 | 7.170M |
| Sep 21, 2026 | 3.14 | 3.16 | 3.04 | 3.10 | 2.005M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 11.21 |
| Twist Bioscience Corp. | 139.92 |
| Beam Therapeutics, Inc. | 24.05 |
| Revolution Medicines, Inc. | 186.99 |
| Prelude Therapeutics, Inc. | 3.63 |
Price Related Metrics
| Price to Book Value | 4.512 |
| Earnings Yield | -32.65% |
| Market Cap | 697.38M |